[pdf-embedder url="http://www.nsorm.com/wp-content/uploads/2018/07/Bone-Marrow-Injections-in-OA-June-2018.pdf" title="Bone Marrow Injections in OA June 2018"]
Osteoarthritis (OA) of the knee is a progressive disease involving the intra-articular (IA) tibiofemoral and patellofemoral cartilage1). Conservative treatment modalities are the first choice in younger and middle-aged populations with cartilage damage and OA of the knee. [pdf-embedder url="http://www.nsorm.com/wp-content/uploads/2018/07/PRP-in-Knee-OA-June-2017.pdf" title="PRP in Knee OA June 2017"]
Osteoarthritis (OA) is a major cause of knee disability involving cartilage damage related to an inadequate healing response in the inflammatory milieu. Current non-surgical treatment modalities include physiotherapy, analgesia, non-steroidal anti-inflammatory drugs, and intra-articular injections, such as hyaluronic acid (HA), corticosteroids, or Ozone, with the purpose of reducing symptoms and improving joint function. [pdf-embedder url="http://www.nsorm.com/wp-content/uploads/2018/07/PRP-in-Tx-of-Osteoarthritis-Pain-and-Physical-Function-Jan-2017.pdf" [...]
Knee osteoarthritis is a degenerative disease that may develop due ageing, obesity, strain, congenital abnormal joints, joint deformity or trauma. It is caused by many factors, such as degradation of articular cartilage injury, joint edge and subchondral bone hyperplasia of reactivity. [pdf-embedder url="http://www.nsorm.com/wp-content/uploads/2018/07/PRP-in-Knee-Osteoarthritis-Mar-2017.pdf" title="PRP in Knee Osteoarthritis Mar 2017"]
Intra-articular injections of platelet-rich plasma (PRP) to treat symptoms of knee osteoarthritis (OA) have been successfully used in young patients and in the early stages of disease. No previous studies have analyzed outcomes of PRP injections during the late stages. [pdf-embedder url="http://www.nsorm.com/wp-content/uploads/2018/07/PRP-in-Advanced-Osteoarthritis.pdf" title="PRP in Advanced Osteoarthritis"]